Financhill
Back

Hepion Pharmaceuticals 10K Form

Sell
43

HEPA
Hepion Pharmaceuticals

Last Price:
2.50
Seasonality Move:
-11.73%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HEPA News And Ratings

See the #1 stock for the next 7 days that we like better than HEPA

HEPA Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-11.23M
Price / Cash Flow: 0
Annual Sales: $3.77
Price / Book: 0.7

Profitability

EPS (TTM): -12.42000
Net Income (TTM): $-44.68M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Hepion Pharmaceuticals Earnings Forecast

Key Hepion Pharmaceuticals Financial Ratios

  • The Interest Expense is -0.02% of Operating Income.
  • Per Share Earnings over the last 9 years have been positive in 5 years.

Hepion Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: HEPA
CUSIP: 426897
Website: hepionpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

HEPA Technical Analysis vs Fundamental Analysis

Sell
43
Hepion Pharmaceuticals (HEPA) is a Sell

Is Hepion Pharmaceuticals a Buy or a Sell?